Research Money Inc.

Canadians need safe and legal access to psychedelic drug therapy, including psilocybin

Guest Contributor
September 1, 2021

Canadians need safe and legally controlled access to psychedelic drug therapy including psilocybin-assisted therapy which, along with providing treatment for palliative patients, would provide opportunities for research and investment, says Michael Kydd, founder and principal of Kydder Group Inc., in an op-ed.

... Please become a Member or to read the rest of this article ...

Other stories mentioning these organizations, people and topics

Organizations:	Canadian Psychedelic Association, Conservative Party, Data Bridge Market Research, Field Trip Health Ltd., Government of Canada, Health Canada, Kydder Group Inc., Nanos Survey, Parliament, and University of Saskatchewan
People:	Dr. (PhD) Erika Dyck, Kerri-Lynn D. Findlay, Michael Kydd, Patty Hajdu, Rick Perry, Rob Moore, Ronan Levy, Thomas Hartle, and Trevor Millar
Topics:	Bill C-7 Medical Assistance in Dying law, Canadian Drugs and Substances Act, drug regulatory reform, global market for psychedelic drugs, palliative patients, psilocybin-assisted therapy, and psychedelic drug therapy

Canadians need safe and legal access to psychedelic drug therapy, including psilocybin

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

Canadians need safe and legal access to psychedelic drug therapy, including psilocybin

Events For Leaders in Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

Events For Leaders in
Science, Tech, Innovation, and Policy